PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29472887-8	2018	Therefore, we hypothesize that administration of PAFR inhibitors, such as Ginkgolide B, PCA 4248 and WEB 2086, have potential to function as a novel therapy for ALS, particularly in SOD1 familial ALS forms.	ginkgolide B	74-86	superoxide dismutase 1	Homo sapiens	182-186	
30815818-8	2019	Experimental data in vitro confirm that GA, GB, GK, and BB resulted in significant decrease of ROS and increase of SOD activities and protein levels of HO-1 and Nqo1; however, GB group had a significant advantage in comparison with the GA and GK groups.	ginkgolide B	44-46	superoxide dismutase 1	Homo sapiens	115-118	
30815818-8	2019	Experimental data in vitro confirm that GA, GB, GK, and BB resulted in significant decrease of ROS and increase of SOD activities and protein levels of HO-1 and Nqo1; however, GB group had a significant advantage in comparison with the GA and GK groups.	ginkgolide B	176-178	superoxide dismutase 1	Homo sapiens	115-118	
30815818-11	2019	Furthermore, GB significantly upregulated the protein levels of HO-1, Nqo1, SOD, p-Akt, p-Nrf2, and Nrf2.	ginkgolide B	13-15	superoxide dismutase 1	Homo sapiens	76-79